Cite
HARVARD Citation
Huttner, A. et al. (n.d.). The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. Lancet infectious diseases. 15 (10), pp. 1156-1166. [Online].